Open AccessValidation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function
Author(s) -
Atsushi Hiraoka,
Kojiro Michitaka,
Takashi Kumada,
Namiki Izumi,
Masumi Kadoya,
Norihiro Kokudo,
Shoji Kubo,
Yutaka Matsuyama,
Osamu Nakashima,
Michiie Sakamoto,
Tadatoshi Takayama,
Takashi Kobayashi,
Kosuke Kashiwabara,
Masatoshi Kudo
Publication year - 2017
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 2235-1795
pISSN - 1664-5553
DOI - 10.1159/000479984
Subject(s) - hepatocellular carcinoma , medicine , gastroenterology , grading (engineering) , bilirubin , liver function , cutoff , hepatic function , civil engineering , physics , quantum mechanics , engineering
Recently, albumin-bilirubin (ALBI) scoring/grading, consisting of only albumin and total bilirubin, has been proposed. We examined the efficacy of this grading system for determining hepatic function in patients with hepatocellular carcinoma (HCC).